|
KIAA1432 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.14429999999744E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.335910E-03 |
| Normal-vs-Stage2 |
2.550100E-04 |
| Normal-vs-Stage3 |
3.89490000000103E-05 |
| Normal-vs-Stage4 |
3.80219999995823E-06 |
| Stage1-vs-Stage2 |
1.360420E-01 |
| Stage1-vs-Stage3 |
8.962200E-02 |
| Stage1-vs-Stage4 |
3.209500E-02 |
| Stage2-vs-Stage3 |
8.200600E-01 |
| Stage2-vs-Stage4 |
6.280600E-01 |
| Stage3-vs-Stage4 |
4.231800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.002210E-04 |
| Normal-vs-AfricanAmerican |
8.016400E-02 |
| Normal-vs-Asian |
3.678800E-03 |
| Caucasian-vs-AfricanAmerican |
4.436600E-01 |
| Caucasian-vs-Asian |
9.431400E-01 |
| AfricanAmerican-vs-Asian |
5.370000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.6123000000039E-05 |
| Normal-vs-Female |
1.165050E-04 |
| Male-vs-Female |
6.017400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.439800E-03 |
| Normal-vs-Age(41-60Yrs) |
4.31899999999708E-05 |
| Normal-vs-Age(61-80Yrs) |
2.54269999999668E-06 |
| Normal-vs-Age(81-100Yrs) |
8.338600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.852400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.456200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.598990E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.412600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.231000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.659600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.892070E-02 |
| Classical-VS-Follicular |
1.227540E-02 |
| Classical-VS-Other |
2.410400E-01 |
| Classical-VS-Normal |
2.036400E-03 |
| Tall-VS-Follicular |
5.320400E-01 |
| Tall-VS-Other |
9.683400E-01 |
| Tall-VS-Normal |
4.43820000000095E-05 |
| Follicular-VS-Other |
7.610000E-01 |
| Follicular-VS-Normal |
3.58129999999957E-05 |
| Other-VS-Normal |
1.907680E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.28279999999748E-05 |
| Normal-vs-N1 |
4.982600E-04 |
| N0-vs-N1 |
9.856400E-01 |
|
|
